Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase. / Oscorbin, Igor P.; Wong, Pei Fong; Boyarskikh, Ulyana A. и др.
в: FEBS Letters, Том 594, № 24, 12.2020, стр. 4338-4356.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase
AU - Oscorbin, Igor P.
AU - Wong, Pei Fong
AU - Boyarskikh, Ulyana A.
AU - Khrapov, Evgeny A.
AU - Filipenko, Maksim L.
N1 - The research was supported by the Russian State Funded Budget Project of ICBFM. Funding for the open access charge: Russian Science Foundation.
PY - 2020/12
Y1 - 2020/12
N2 - Reverse transcriptases (RTs) are a standard tool in both fundamental studies and diagnostics. RTs should possess elevated temperature optimum, high thermal stability, processivity and tolerance to contaminants. Here, we constructed a set of chimeric RTs, based on the combination of the Moloney murine leukaemia virus (M-MuLV) RT and either of two DNA-binding domains: the DNA-binding domain of the DNA ligase from Pyrococcus abyssi or the DNA-binding Sto7d protein from Sulfolobus tokodaii. The processivity and efficiency of cDNA synthesis of the chimeric RT with Sto7d at the C-end are increased several fold. The attachment of Sto7d enhances the tolerance of M-MuLV RT to the most common amplification inhibitors: NaCl, urea, guanidinium chloride, formamide, components of human whole blood and human blood plasma. Thus, fusing M-MuLV RT with an additional domain results in more robust and efficient RTs.
AB - Reverse transcriptases (RTs) are a standard tool in both fundamental studies and diagnostics. RTs should possess elevated temperature optimum, high thermal stability, processivity and tolerance to contaminants. Here, we constructed a set of chimeric RTs, based on the combination of the Moloney murine leukaemia virus (M-MuLV) RT and either of two DNA-binding domains: the DNA-binding domain of the DNA ligase from Pyrococcus abyssi or the DNA-binding Sto7d protein from Sulfolobus tokodaii. The processivity and efficiency of cDNA synthesis of the chimeric RT with Sto7d at the C-end are increased several fold. The attachment of Sto7d enhances the tolerance of M-MuLV RT to the most common amplification inhibitors: NaCl, urea, guanidinium chloride, formamide, components of human whole blood and human blood plasma. Thus, fusing M-MuLV RT with an additional domain results in more robust and efficient RTs.
KW - cDNA synthesis
KW - chimeric protein
KW - M-MuLV reverse transcriptase
KW - protein engineering
KW - reverse transcription
KW - VIRUS
KW - RNA
KW - PERFORMANCE
KW - POLYMERASE
KW - AVIAN-MYELOBLASTOSIS
KW - AMPLIFICATION
KW - INCREASE
KW - GENERATION
KW - THERMOSTABILITY
KW - RIBONUCLEASE
UR - http://www.scopus.com/inward/record.url?scp=85092027910&partnerID=8YFLogxK
U2 - 10.1002/1873-3468.13934
DO - 10.1002/1873-3468.13934
M3 - Article
C2 - 32970841
AN - SCOPUS:85092027910
VL - 594
SP - 4338
EP - 4356
JO - FEBS Letters
JF - FEBS Letters
SN - 0014-5793
IS - 24
ER -
ID: 25677196